cfDNA Methylation for Liver Cancer Recurrence Detection — Stella

stellabeta Find trials matched to me Trial Match

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

cfDNA Methylation for Liver Cancer Recurrence Detection — Stella

Recruiting

Back to Primary Liver Cancer trials

Trial locations(1 site)

China

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei

Key details

Sponsor

Wuhan Ammunition Life-tech Co., Ltd

Enrollment target

~500 participants

Started

September 2025

Primary completion

June 2027

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov